Pds Planning, Inc Pfizer Inc Transaction History

Pds Planning, Inc

$986 Million
Q2 2024

A detailed history of Pds Planning, Inc transactions in Pfizer Inc stock. As of the latest transaction made, Pds Planning, Inc holds 28,209 shares of PFE stock, worth $816,368. This represents 0.08% of its overall portfolio holdings.

Number of Shares

28,209

Previous 24,405 15.59%

Holding current value

$816,368

Previous $677,000 16.54%

% of portfolio

0.08%

Previous 0.07%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$25.26 - $29.6 $96,089 - $112,598	3,804 Added 15.59%	28,209 $789,000
Q1 2024 May 01, 2024	SELL	$25.89 - $29.73 $31,145 - $35,765	-1,203 Reduced 4.7%	24,405 $677,000
Q4 2023 Feb 01, 2024	BUY	$26.13 - $33.94 $25,293 - $32,853	968 Added 3.93%	25,608 $737,000
Q3 2023 Oct 20, 2023	SELL	$32.09 - $37.51 $89,306 - $104,390	-2,783 Reduced 10.15%	24,640 $817,000
Q2 2023 Jul 20, 2023	SELL	$36.12 - $41.79 $33,736 - $39,031	-934 Reduced 3.29%	27,423 $1.01 Million
Q1 2023 May 01, 2023	BUY	$39.39 - $51.28 $360,536 - $469,365	9,153 Added 47.66%	28,357 $1.16 Million
Q4 2022 Jan 26, 2023	BUY	$41.75 - $54.5 $24,465 - $31,937	586 Added 3.15%	19,204 $0
Q3 2022 Nov 02, 2022	SELL	$43.76 - $53.42 $17,197 - $20,994	-393 Reduced 2.07%	18,618 $815,000
Q2 2022 Jul 15, 2022	BUY	$46.53 - $55.17 $930 - $1,103	20 Added 0.11%	19,011 $997,000
Q1 2022 Apr 18, 2022	BUY	$45.75 - $56.69 $223,626 - $277,100	4,888 Added 34.66%	18,991 $983,000
Q4 2021 Jan 25, 2022	SELL	$41.32 - $61.25 $185,485 - $274,951	-4,489 Reduced 24.14%	14,103 $833,000
Q3 2021 Oct 22, 2021	BUY	$39.25 - $50.42 $17,858 - $22,941	455 Added 2.51%	18,592 $800,000
Q2 2021 Jul 26, 2021	BUY	$35.91 - $40.68 $51,638 - $58,497	1,438 Added 8.61%	18,137 $710,000
Q1 2021 Apr 20, 2021	BUY	$33.49 - $37.77 $4,454 - $5,023	133 Added 0.8%	16,699 $605,000
Q4 2020 Jan 21, 2021	BUY	$33.47 - $42.56 $55,995 - $71,202	1,673 Added 11.23%	16,566 $610,000
Q3 2020 Oct 19, 2020	BUY	$31.75 - $37.25 $36,449 - $42,763	1,148 Added 8.35%	14,893 $547,000
Q2 2020 Aug 11, 2020	BUY	$30.12 - $36.54 $33,794 - $40,997	1,122 Added 8.89%	13,745 $449,000
Q1 2020 Apr 20, 2020	SELL	$27.03 - $38.62 $21,272 - $30,393	-787 Reduced 5.87%	12,623 $412,000
Q4 2019 Feb 07, 2020	BUY	$32.92 - $37.36 $37,100 - $42,104	1,127 Added 9.18%	13,410 $525,000
Q3 2019 Oct 28, 2019	BUY	$32.49 - $42.13 $106,794 - $138,481	3,287 Added 36.54%	12,283 $441,000
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $7,137 - $8,013	193 Added 2.19%	8,996 $390,000
Q1 2019 Apr 19, 2019	BUY	$37.5 - $41.2 $13,875 - $15,244	370 Added 4.39%	8,803 $374,000
Q4 2018 Feb 08, 2019	BUY	$38.47 - $43.86 $9,886 - $11,272	257 Added 3.14%	8,433 $368,000
Q3 2018 Nov 02, 2018	BUY	$34.47 - $41.81 $61,839 - $75,007	1,794 Added 28.11%	8,176 $360,000
Q2 2018 Jul 27, 2018	BUY	$32.98 - $35.16 $197 - $210	6 Added 0.09%	6,382 $232,000
Q1 2018 May 03, 2018	SELL	$31.91 - $37.02 $1,372 - $1,591	-43 Reduced 0.67%	6,376 $226,000
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $213,495 - $226,526	6,419	6,419 $232,000

Others Institutions Holding PFE

# of Institutions

3,222

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $162B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pds Planning, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pds Planning, Inc with notifications on news.

Account